XWELL (XWEL) Short Interest

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XWEL XWELL Inc XWEL
27 GF Score
Price $0.99
GF Value $0.86
Valuation Modestly Overvalued
! 4 Warning Signs
View Full Analysis

What is XWELL Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.


XWEL vs MBAI, NDRA, BIAF: Short Interest Comparison

For the Diagnostics & Research subindustry, XWELL's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


XWELL Short Interest vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, XWELL's Short Interest distribution charts can be found below:

* The bar in red indicates where XWELL's Short Interest falls into.


XWEL
27GF Score
XWELL Inc XWEL
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is XWELL (XWEL) Overvalued in 2026?

Based on GuruFocus' analysis, XWELL stock appears to be overvalued. The current stock price of $0.99 is trading 15.5% above its estimated GF Value™ of $0.86. GuruFocus considers XWELL to be Modestly Overvalued.

Key valuation signals for XWEL:

  • Short Interest:
  • GF Value™: $0.86 vs. price of $0.99 (15.5% above fair value)
  • GF Score™: 27/100 with 4 warning signs

No single metric tells the full story. See the XWEL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


XWELL Business Description

Address 254 West 31st Street, 11th Floor, New York, NY, USA, 10001
XWELL Inc is an international wellness organization dedicated to delivering restorative and health-focused services to travelers through its three reportable operating segments: XpresSpa, XpresTest, and Naples Wax Center. The XpresSpa segment, which generates maximum revenue, operates spa service locations in airports, offering massage, skincare, and travel products. The XpresTest segment provides aircraft wastewater and passenger nasal sampling through the CDC's bio-surveillance program. The Naples Wax Center segment operates six locations offering face and body waxing, skincare services, and cosmetic products. The Company generates maximum revenue from the United States.
27GF Score

Get the complete analysis for XWEL

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.99
Price
$0.86
GF Value